Although HIV infection remains a global public health challenge, ART has transformed it from a fatal illness to a manageable lifetime condition for those who are successfully being treated.Initially, ...
IMPAACT 2017 (MOCHA) week 96 results show long-acting Cabenuva (cabotegravir + rilpivirine) effectively maintained viral suppression in 94.4% of adolescents aged 12 to <18 years Additional paediatric ...
An average of one baby a week in the Southern Health region is being given a preventive treatment after a potential measles ...
The treatment of a Trikkur resident who lost his eyesight due to alleged medical negligence at Thrissur Medical College began on Monday at an eye hospital in Coimbatore.
FDA expands Sogroya approval for pediatric patients with Noonan syndrome, idiopathic short stature, and those born small for gestational age.
TerSera Therapeutics LLC today announced that it has completed the previously announced sale of its Infusion Specialty Therapies Business Unit (IST), including two specialty medications, Prialt® ...
The RAINIER trial met its primary endpoint, showing that povetacicept effectively reduces proteinuria in patients with immunoglobulin A nephropathy. Povetacicept, an investigational BAFF (B-cell ...
Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved three new indications for once-weekly Sogroya (R) (somapacitan-beco) injection 5 mg, 10 mg, or 15 mg, a ...
In a matter of relief for the family members of Imran Khan, his supporters across the world and the PTI leader himself, Imran ...
Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced ...
Walk into a Miami med spa and leave with “brighter, more even skin tone” delivered via exosome microneedle injections in your face. Or visit a Winter Haven med spa and get ...
Teclistamab plus daratumumab and hyaluronidase-fihj is approved for relapsed or refractory MM after one prior line of therapy, including a proteasome inhibitor and immunomodulatory agent.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results